Thomas Schreiner

4.0k total citations
84 papers, 2.8k citations indexed

About

Thomas Schreiner is a scholar working on Endocrinology, Diabetes and Metabolism, Social Psychology and Molecular Biology. According to data from OpenAlex, Thomas Schreiner has authored 84 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Endocrinology, Diabetes and Metabolism, 20 papers in Social Psychology and 17 papers in Molecular Biology. Recurrent topics in Thomas Schreiner's work include LGBTQ Health, Identity, and Policy (19 papers), Growth Hormone and Insulin-like Growth Factors (13 papers) and Pituitary Gland Disorders and Treatments (12 papers). Thomas Schreiner is often cited by papers focused on LGBTQ Health, Identity, and Policy (19 papers), Growth Hormone and Insulin-like Growth Factors (13 papers) and Pituitary Gland Disorders and Treatments (12 papers). Thomas Schreiner collaborates with scholars based in Norway, Germany and Belgium. Thomas Schreiner's co-authors include Guy T’Sjoen, Alessandra D. Fisher, Jens Bollerslev, Eva Van Caenegem, Katrien Wierckx, Martin den Heijer, Kaatje Toye, Jean‐Marc Kaufman, Trine Bjøro and Øystein Krüger and has published in prestigious journals such as New England Journal of Medicine, Blood and Endocrine Reviews.

In The Last Decade

Thomas Schreiner

81 papers receiving 2.7k citations

Peers

Thomas Schreiner
Shari Goldfarb United States
Neil E. Martin United States
Kirstin Pirie United Kingdom
Ann Danoff United States
Pamela N. Schultz United States
Louise Baxter United Kingdom
Daniel E. Kenady United States
Gregory A. Broderick United States
Thomas Schreiner
Citations per year, relative to Thomas Schreiner Thomas Schreiner (= 1×) peers Irene Halperín

Countries citing papers authored by Thomas Schreiner

Since Specialization
Citations

This map shows the geographic impact of Thomas Schreiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Schreiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Schreiner more than expected).

Fields of papers citing papers by Thomas Schreiner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Schreiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Schreiner. The network helps show where Thomas Schreiner may publish in the future.

Co-authorship network of co-authors of Thomas Schreiner

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Schreiner. A scholar is included among the top collaborators of Thomas Schreiner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Schreiner. Thomas Schreiner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schreiner, Thomas, et al.. (2025). Dynamics of pre-release consumer buzz: Driving communication, search, and participation for market performance. Journal of the Academy of Marketing Science. 53(5). 1261–1281.
2.
Schreiner, Thomas, et al.. (2024). The role of consumer-based brand equity on the prolongation of trademarks. Journal of Brand Management. 32(2). 94–108. 2 indexed citations
3.
4.
Limmroth, Volker, et al.. (2017). Autoinjector preference among patients with multiple sclerosis: results from a national survey. Patient Preference and Adherence. Volume 11. 1325–1334. 9 indexed citations
5.
Klaver, Maartje, Chantal M Wiepjes, Nienke M. Nota, et al.. (2017). Breast Development in Transwomen After 1 Year of Cross-Sex Hormone Therapy: Results of a Prospective Multicenter Study. The Journal of Clinical Endocrinology & Metabolism. 103(2). 532–538. 70 indexed citations
6.
Wiepjes, Chantal M, Mariska Vlot, Maartje Klaver, et al.. (2017). Bone Mineral Density Increases in Trans Persons After 1 Year of Hormonal Treatment: A Multicenter Prospective Observational Study. Journal of Bone and Mineral Research. 32(6). 1252–1260. 57 indexed citations
7.
Fuchs, H., M. Alber, Thomas Schreiner, & Dietmar Georg. (2015). Implementation of spot scanning dose optimization and dose calculation for helium ions in Hyperion. Medical Physics. 42(9). 5157–5166. 15 indexed citations
8.
Caenegem, Eva Van, Katrien Wierckx, Youri Taes, et al.. (2014). Body composition, bone turnover, and bone mass in trans men during testosterone treatment: 1-year follow-up data from a prospective case–controlled study (ENIGI). European Journal of Endocrinology. 172(2). 163–171. 114 indexed citations
9.
Schreiner, Thomas, et al.. (2012). Comparison of basic features of proton and helium ion pencil beams in water using GATE. Zeitschrift für Medizinische Physik. 22(3). 170–178. 22 indexed citations
10.
Farholt, Stense, Jens Bollerslev, Thomas Schreiner, et al.. (2011). Growth hormone treatment in adults with Prader-Willi syndrome: the Scandinavian study. Endocrine. 41(2). 191–199. 38 indexed citations
11.
Farholt, Stense, Jens Bollerslev, Thomas Schreiner, et al.. (2010). One Year of Growth Hormone Treatment in Adults with Prader-Willi Syndrome Improves Body Composition: Results from a Randomized, Placebo-Controlled Study. The Journal of Clinical Endocrinology & Metabolism. 95(11). 4943–4950. 43 indexed citations
12.
Ueland, Thor, Stine Lyngvi Fougner, Kristin Godang, et al.. (2009). Associations between Body Composition, Circulating Interleukin-1 Receptor Antagonist, Osteocalcin, and Insulin Metabolism in Active Acromegaly. The Journal of Clinical Endocrinology & Metabolism. 95(1). 361–368. 34 indexed citations
13.
Carlsen, Sven Magnus, Morten Lund‐Johansen, Thomas Schreiner, et al.. (2008). Preoperative Octreotide Treatment in Newly Diagnosed Acromegalic Patients with Macroadenomas Increases Cure Short-Term Postoperative Rates: A Prospective, Randomized Trial. The Journal of Clinical Endocrinology & Metabolism. 93(8). 2984–2990. 152 indexed citations
14.
Schreiner, Thomas, et al.. (2004). Immediate Drug Release from Solid Oral Dosage Forms. Journal of Pharmaceutical Sciences. 94(1). 120–133. 22 indexed citations
15.
Lund‐Johansen, Morten, Sylvi Aanderud, Thomas Schreiner, et al.. (2003). Ikke-hormonproduserende hypofyseadenomer. Tidsskrift for Den Norske Laegeforening. 1 indexed citations
16.
Schreiner, Thomas, et al.. (2001). First experience with a ready-for-use rheohemapheresis system. Transfusion and Apheresis Science. 24(2). 125–128. 2 indexed citations
17.
Bjøro, Trine, et al.. (2000). Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord-Trondelag (HUNT). European Journal of Endocrinology. 143(5). 639–647. 369 indexed citations
18.
Schwarz, Klaus, et al.. (1999). Definition of a critical T cell threshold for prevention of GVHD after HLA non-identical PBPC transplantation in children. Bone Marrow Transplantation. 24(6). 575–581. 35 indexed citations
19.
Schreiner, Thomas, et al.. (1998). Collection of allogeneic peripheral blood progenitor cells by two protocols on an apheresis system. Transfusion. 38(11-12). 1051–1055. 29 indexed citations
20.
Wiesneth, Markus, Thomas Schreiner, N. Frickhofen, et al.. (1995). Mobilization and Collection of Allogeneic and Autologous Peripheral Blood Progenitor Cells for Transplantation. Transfusion Medicine and Hemotherapy. 22(Suppl. 1). 116–118. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026